Effect of an Academic Detailing Intervention on the Utilization Rate of Cyclooxygenase-2 Inhibitors in the ElderlyGRAHAM, Stephen D; HARTZEMA, Abraham G; SKETRIS, Ingrid S et al.The Annals of pharmacotherapy. 2008, Vol 42, Num 6, pp 749-756, issn 1060-0280, 8 p.Article

Selective cyclooxygenase-2 inhibitors: similarities and differencesBRUNE, K; HINZ, B.Scandinavian journal of rheumatology. 2004, Vol 33, Num 1, pp 1-6, issn 0300-9742, 6 p.Article

Indole based cyclooxygenase inhibitors: Synthesis, biological evaluation, docking and NMR screeningESTEVAO, Monica S; CARVALHO, Lufsa C. R; FREITAS, Marisa et al.European journal of medicinal chemistry. 2012, Vol 54, pp 823-833, issn 0223-5234, 11 p.Article

Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?MASCLEE, G. M. C; VALKHOFF, V. E; STURKENBOOM, M. C. J. M et al.Alimentary pharmacology & therapeutics. 2013, Vol 38, Num 2, pp 178-189, issn 0269-2813, 12 p.Article

Faut-il un éditorial de plus sur les coxibs ? = Is a further editorial on coxibs required?BERGMANN, J.-F; CHAMPION, K; MOULY, S et al.La Presse médicale (1983). 2005, Vol 34, Num 10, pp 699-700, issn 0755-4982, 2 p.Article

COX-2-Hemmer und kardiovaskuläre Ereignisse = COX-2 inhibitors and cardiovascular eventsKÖTTER, I.Zeitschrift für Rheumatologie (Print). 2007, Vol 66, Num 3, issn 0340-1855, 243-246 [3 p.]Article

Selective cyclooxygenase 2 inhibitors and cardiovascular eventsSOLOMON, Daniel H.Arthritis and rheumatism. 2005, Vol 52, Num 7, pp 1968-1978, issn 0004-3591, 11 p.Article

Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancerCHOW, Louis Wing-Cheong; YIP, Adrian Yun-San; LOO, Wings Tjing-Yung et al.Journal of steroid biochemistry and molecular biology. 2008, Vol 111, Num 1-2, pp 13-17, issn 0960-0760, 5 p.Article

Accelerative effect of a selective cyclooxygenase-2 inhibitor on Fas-mediated apoptosis in human neutrophilsIWASE, Masayasu; TAKAOKA, Sayaka; UCHIDA, Makiko et al.International immunopharmacology. 2006, Vol 6, Num 3, pp 334-341, issn 1567-5769, 8 p.Article

Pharmacological profile of celecoxib, a specific cyclooxygenase-2 inhibitorYOSHINO, Taiji; KIMOTO, Aishi; KOBAYASHI, Seiji et al.Arzneimittel-Forschung. 2005, Vol 55, Num 7, pp 394-402, issn 0004-4172, 9 p.Article

Etoricoxib : A highly selective COX-2 inhibitorMARTINA, Shaunta D; VESTA, Kimi S; RIPLEY, Toni L et al.The Annals of pharmacotherapy. 2005, Vol 39, Num 5, pp 854-862, issn 1060-0280, 9 p.Article

Cyclooxygenase-2 inhibitors dilemma in cardiovascular medicine : Are all family members bad players?CELIK, Turgay; IYISOY, Atila; KURSAKLIOGLU, Hurkan et al.International journal of cardiology. 2007, Vol 116, Num 2, pp 259-260, issn 0167-5273, 2 p.Article

Celecoxib augmentation of continuously III patients with schizophreniaRAPAPORT, Mark Hyman; DELRAHIM, Katia K; BRESEE, Catherine J et al.Biological psychiatry (1969). 2005, Vol 57, Num 12, pp 1594-1596, issn 0006-3223, 3 p.Article

Nonsteroidal Anti-inflammatory Drugs and Anastomotic Dehiscence in Bowel Surgery: Systematic Review and Meta-Analysis of Randomized, Controlled TrialsBURTON, Thomas P; MITTAL, Anubhav; SOO, Mattias et al.Diseases of the colon & rectum. 2013, Vol 56, Num 1, pp 126-134, issn 0012-3706, 9 p.Article

Long-Term Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drug Use According to Time Passed After First-Time Myocardial Infarction: A Nationwide Cohort StudySCHJERNING OLSEN, Anne-Marie; FOSBØL, Emil L; HANSEN, Peter R et al.Circulation (New York, N.Y.). 2012, Vol 126, Num 16, pp 1955-1963, issn 0009-7322, 9 p.Article

Risk of congestive heart failure with nonsteroidal antiinflammatory drugs and selective cyclooxygenase 2 inhibitors : A class effect?HUDSON, Marie; RAHME, Elham; RICHARD, Hugues et al.Arthritis care and research. 2007, Vol 57, Num 3, pp 516-523, issn 0893-7524, 8 p.Article

2,4,5-TMBA, a Natural Inhibitor of Cyclooxygenase-2, Suppresses Adipogenesis and Promotes Lipolysis in 3T3-L1 AdipocytesWU, Man-Ru; HOU, Ming-Hon; LIN, Ya-Lin et al.Journal of agricultural and food chemistry (Print). 2012, Vol 60, Num 29, pp 7242-7249, issn 0021-8561, 8 p.Article

A Novel COX-2 Inhibitor Pyrazole Derivative Proven Effective as an Anti-Inflammatory and Analgesic DrugMOHY EL-DIN, Mahmoud M; SENBEL, Amira M; BISTAWROOS, Azza A et al.Basic & clinical pharmacology & toxicology (Print). 2011, Vol 108, Num 4, pp 263-273, issn 1742-7835, 11 p.Article

Ocular adverse effects associated with cyclooxygenase-2 inhibitorsFRAUNFELDER, Frederick W; SOLOMON, Jonathan; MEHELAS, Thomas J et al.Archives of ophthalmology (1960). 2006, Vol 124, Num 2, pp 277-279, issn 0003-9950, 3 p.Article

Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitorsFISCHER, Michael A; SCHNEEWEISS, Sebastian; AVORN, Jerry et al.The New England journal of medicine. 2004, Vol 351, Num 21, pp 2187-2194, issn 0028-4793, 8 p.Article

Informed choice and the widespread use of antiinflammatory drugsFRAENKEL, Liana; WITTINK, Dick R; CONCATO, John et al.Arthritis care and research. 2004, Vol 51, Num 2, pp 210-214, issn 0893-7524, 5 p.Article

COX-2 Selective Inhibitors in the Treatment of OsteoarthritisLAINE, Loren; WHITE, William B; ROSTOM, Alaa et al.Seminars in arthritis and rheumatism. 2008, Vol 38, Num 3, pp 165-187, issn 0049-0172, 23 p.Article

Antipyretic analgesics : Nonsteroidal antiinflammatory drugs, selective COX-2 inhibitors, paracetamol and pyrazolinonesHINZ, B; BRUNE, K.Handbook of experimental pharmacology. 2006, Vol 177, pp 65-93, issn 0171-2004, 29 p.Article

Factors associated with celecoxib and rofecoxib utilizationRAWSON, Nigel S. B; NOURJAH, Parivash; GROSSER, Stella C et al.The Annals of pharmacotherapy. 2005, Vol 39, Num 4, pp 597-602, issn 1060-0280, 6 p.Article

Preoperative use of selective COX-II inhibitors for pain management in laparoscopic Nissen fundoplicationALANOGLU, Z; ATES, Y; ORBEY, B. C et al.Surgical endoscopy. 2005, Vol 19, Num 9, pp 1182-1187, issn 0930-2794, 6 p.Article